News & Events

Harvard medical school and ISK Ltd submitted a grant application for a clinical trial with Alzheimer’s patients

13 Apr|

ISK Ltd and Harvard medical school submitted together grant application to support phase 1B clinical trial for treatment of Alzheimer’s disease.

Read More

PHASE 1B/2A Clinical trial started

13 Apr|

The Nerofe Phase 1B/2A trial with high risk MDS and AML patients is taking place at the University of Miami Sylvester Comprehensive Cancer Center.

Read More

ISK received the FDA’s approval to start Phase 1b/2a with AML patients

09 Jan|

Read More

Cooperation with Harvard Medical School (MGH)

27 Oct|

ISK has signed an agreement for cooperation with Harvard Medical School for drug development to treat neurodegenerative diseases

Read More